|View printer-friendly version|
|Gilead Announces 10-Year, $100 Million Commitment to Address the HIV/AIDS Epidemic in the Southern United States|
-- New Initiative Mobilizes Local Communities to Implement Solutions --
“HIV/AIDS remains an urgent public health crisis in
According to the
“Limited access to healthcare and information about life-saving advances
in HIV treatment and prevention in the most vulnerable communities
creates an environment where we, as a society, have the tools in hand to
improve lives, but these resources are not being fully utilized to
address the epidemic,” said Dr.
About the Gilead COMPASS Initiative
The Gilead COMPASS Initiative is a
About Gilead’s Commitment in HIV
For nearly 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention, testing and linkage to care and cure research. In further efforts to end the HIV/AIDS epidemic, Gilead is conducting early-stage clinical research to identify novel agents and strategies that could play a role in eradicating HIV infection in the body.
Gilead’s corporate giving program aims to reduce disparities, provide access, advance education and support local communities. In 2016, Funders Concerned About AIDS (FCAA) recognized Gilead as the leading corporate global funder of HIV/AIDS programs, and second overall behind the Bill & Melinda Gates Foundation.
About Gilead Sciences
For more information on
1 CDC. HIV in
3 CDC. HIV in the
4 Valdiserri RO. HIV/AIDS Stigma: An Impediment to Public
Quotes from Coordinating Centers
“Community-based organizations faced with diminishing long-term
financial resources and increased community needs are challenged to ‘do
more with less,’” said
“We’re grateful for this opportunity to fight such an important, yet
challenging, fight,” said
“We can end the HIV epidemic in the Southern United States,” said
Gilead Sciences, Inc.
Minimum 20 minute delay